124 related articles for article (PubMed ID: 37788055)
1. Evaluation of [
Haider A; Wang L; Gobbi L; Li Y; Chaudhary A; Zhou X; Chen J; Zhao C; Rong J; Xiao Z; Hou L; Elghazawy NH; Sippl W; Davenport AT; Daunais JB; Ahmed H; Crowe R; Honer M; Rominger A; Grether U; Liang SH; Ametamey SM
ACS Chem Neurosci; 2023 Oct; 14(20):3752-3760. PubMed ID: 37788055
[TBL] [Abstract][Full Text] [Related]
2. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Gobbi L; Kretz J; Ullmer C; Brink A; Honer M; Woltering TJ; Muri D; Iding H; Bürkler M; Binder M; Bartelmus C; Knuesel I; Pacher P; Herde AM; Spinelli F; Ahmed H; Atz K; Keller C; Weber M; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2020 Sep; 63(18):10287-10306. PubMed ID: 32787079
[TBL] [Abstract][Full Text] [Related]
3. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI.
Ni R; Müller Herde A; Haider A; Keller C; Louloudis G; Vaas M; Schibli R; Ametamey SM; Klohs J; Mu L
Mol Imaging Biol; 2022 Oct; 24(5):700-709. PubMed ID: 34642898
[TBL] [Abstract][Full Text] [Related]
4. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands.
Kallinen A; Mardon K; Lane S; Montgomery AP; Bhalla R; Stimson DHR; Ahamed M; Cowin GJ; Hibbs D; Werry EL; Fulton R; Connor M; Kassiou M
ACS Chem Neurosci; 2023 Aug; 14(16):2902-2921. PubMed ID: 37499194
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.
Evens N; Vandeputte C; Muccioli GG; Lambert DM; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
Bioorg Med Chem; 2011 Aug; 19(15):4499-505. PubMed ID: 21737287
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of [
Attili B; Celen S; Ahamed M; Koole M; Haute CVD; Vanduffel W; Bormans G
Br J Pharmacol; 2019 May; 176(10):1481-1491. PubMed ID: 30588600
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Mu L; Bieri D; Slavik R; Drandarov K; Müller A; Cermak S; Weber M; Schibli R; Krämer SD; Ametamey SM
J Neurochem; 2013 Sep; 126(5):616-24. PubMed ID: 23795580
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.
Hortala L; Arnaud J; Roux P; Oustric D; Boulu L; Oury-Donat F; Avenet P; Rooney T; Alagille D; Barret O; Tamagnan G; Barth F
Bioorg Med Chem Lett; 2014 Jan; 24(1):283-7. PubMed ID: 24291040
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 4-oxo-quinoline-based CB2 PET radioligands in R6/2 chorea huntington mouse model and human ALS spinal cord tissue.
Haider A; Spinelli F; Herde AM; Mu B; Keller C; Margelisch M; Weber M; Schibli R; Mu L; Ametamey SM
Eur J Med Chem; 2018 Feb; 145():746-759. PubMed ID: 29353725
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of [
Hansen HD; Constantinescu CC; Barret O; Herth MM; Magnussen JH; Lehel S; Dyssegaard A; Colomb J; Billard T; Zimmer L; Tamagnan G; Knudsen GM
J Labelled Comp Radiopharm; 2019 Jan; 62(1):34-42. PubMed ID: 30414212
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Analysis of
Takano A; Chen L; Nag S; Brodney MA; Arakawa R; Chang C; Amini N; Doran SD; Dutra JK; McCarthy TJ; Nolan CE; O'Neill BT; Villalobos A; Zhang L; Halldin C
J Nucl Med; 2019 Jul; 60(7):992-997. PubMed ID: 30530832
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis and
Bdair H; Singleton TA; Ross K; Jolly D; Kang MS; Aliaga A; Tuznik M; Kaur T; Yous S; Soucy JP; Massarweh G; Scott PJH; Koeppe R; Spadoni G; Bedini A; Rudko DA; Gobbi G; Benkelfat C; Rosa-Neto P; Brooks AF; Kostikov A
ACS Chem Neurosci; 2022 May; 13(9):1382-1394. PubMed ID: 35420022
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Design, Optimization, and Development of [
Gündel D; Deuther-Conrad W; Ueberham L; Kaur S; Otikova E; Teodoro R; Toussaint M; Lai TH; Clauß O; Scheunemann M; Bormans G; Bachmann M; Kopka K; Brust P; Moldovan RP
J Med Chem; 2022 Jul; 65(13):9034-9049. PubMed ID: 35771668
[TBL] [Abstract][Full Text] [Related]
18. Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor.
Spinelli F; Mu L; Ametamey SM
J Labelled Comp Radiopharm; 2018 Mar; 61(3):299-308. PubMed ID: 29110331
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Characterization of Two
Liu H; Jin H; Luo Z; Yue X; Zhang X; Flores H; Su Y; Perlmutter JS; Tu Z
ACS Chem Neurosci; 2018 May; 9(5):1066-1073. PubMed ID: 29400443
[TBL] [Abstract][Full Text] [Related]
20. Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor.
Moldovan RP; Teodoro R; Gao Y; Deuther-Conrad W; Kranz M; Wang Y; Kuwabara H; Nakano M; Valentine H; Fischer S; Pomper MG; Wong DF; Dannals RF; Brust P; Horti AG
J Med Chem; 2016 Sep; 59(17):7840-55. PubMed ID: 27500461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
